Global Blood Tests for Alzheimer's Diagnosis Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Blood Tests for Alzheimer's Diagnosis market size was valued at US$ 74.24 million in 2025 and is forecast to a readjusted size of US$ 131 million by 2032 with a CAGR of 8.4% during review period.
Blood Tests for Alzheimer's Diagnosis refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500?900 per test.
The upstream supply chain of Blood Tests for Alzheimer's Diagnosis mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, A?, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer?s disease biomarker research.
The Blood Tests for Alzheimer's Diagnosis market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, A?, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer?s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
This report is a detailed and comprehensive analysis for global Blood Tests for Alzheimer's Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Tests for Alzheimer's Diagnosis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Blood Tests for Alzheimer's Diagnosis refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500?900 per test.
The upstream supply chain of Blood Tests for Alzheimer's Diagnosis mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, A?, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer?s disease biomarker research.
The Blood Tests for Alzheimer's Diagnosis market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, A?, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer?s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
This report is a detailed and comprehensive analysis for global Blood Tests for Alzheimer's Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Blood Tests for Alzheimer's Diagnosis market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Blood Tests for Alzheimer's Diagnosis
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Tests for Alzheimer's Diagnosis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Single Biomarker Tests
- Multi-Biomarker Panel Tests
- Others
- Chemiluminescent Immunoassay
- Single-Molecule and Ultra-Sensitive Immunoassay
- Mass Spectrometry-Based Testing
- Others
- Clinical Use
- Non-Clinical Use
- Roche
- Fujirebio
- Sysmex
- Shimadzu
- Diadem
- Quanterix
- ALZpath
- Beckman Coulter Diagnostics
- Siemens Healthineers
- Vazyme
- Hoyotek
- BGI Genomics
- Kemei Diagnostics
- Maya Lightyear
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
- Chapter 1, to describe Blood Tests for Alzheimer's Diagnosis product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top players of Blood Tests for Alzheimer's Diagnosis, with revenue, gross margin, and global market share of Blood Tests for Alzheimer's Diagnosis from 2021 to 2026.
- Chapter 3, the Blood Tests for Alzheimer's Diagnosis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
- Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Blood Tests for Alzheimer's Diagnosis market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
- Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
- Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Tests for Alzheimer's Diagnosis.
- Chapter 13, to describe Blood Tests for Alzheimer's Diagnosis research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood Tests for Alzheimer's Diagnosis by Type
1.3.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type in 2025
1.3.3 Single Biomarker Tests
1.3.4 Multi-Biomarker Panel Tests
1.3.5 Others
1.4 Classification of Blood Tests for Alzheimer's Diagnosis Commercialization Status
1.4.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status: 2021 Versus 2025 Versus 2032
1.4.2 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share Commercialization Status in 2025
1.4.3 Chemiluminescent Immunoassay
1.4.4 Single-Molecule and Ultra-Sensitive Immunoassay
1.4.5 Mass Spectrometry-Based Testing
1.4.6 Others
1.5 Global Blood Tests for Alzheimer's Diagnosis Market by Application
1.5.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Application: 2021 Versus 2025 Versus 2032
1.5.2 Clinical Use
1.5.3 Non-Clinical Use
1.6 Global Blood Tests for Alzheimer's Diagnosis Market Size & Forecast
1.7 Global Blood Tests for Alzheimer's Diagnosis Market Size and Forecast by Region
1.7.1 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
1.7.2 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region, (2021-2032)
1.7.3 North America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
1.7.4 Europe Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
1.7.5 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
1.7.6 South America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
1.7.7 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.1.4 Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments and Future Plans
2.2 Fujirebio
2.2.1 Fujirebio Details
2.2.2 Fujirebio Major Business
2.2.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.2.4 Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Fujirebio Recent Developments and Future Plans
2.3 Sysmex
2.3.1 Sysmex Details
2.3.2 Sysmex Major Business
2.3.3 Sysmex Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.3.4 Sysmex Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sysmex Recent Developments and Future Plans
2.4 Shimadzu
2.4.1 Shimadzu Details
2.4.2 Shimadzu Major Business
2.4.3 Shimadzu Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.4.4 Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Shimadzu Recent Developments and Future Plans
2.5 Diadem
2.5.1 Diadem Details
2.5.2 Diadem Major Business
2.5.3 Diadem Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.5.4 Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Diadem Recent Developments and Future Plans
2.6 Quanterix
2.6.1 Quanterix Details
2.6.2 Quanterix Major Business
2.6.3 Quanterix Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.6.4 Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Quanterix Recent Developments and Future Plans
2.7 ALZpath
2.7.1 ALZpath Details
2.7.2 ALZpath Major Business
2.7.3 ALZpath Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.7.4 ALZpath Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 ALZpath Recent Developments and Future Plans
2.8 Beckman Coulter Diagnostics
2.8.1 Beckman Coulter Diagnostics Details
2.8.2 Beckman Coulter Diagnostics Major Business
2.8.3 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.8.4 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Beckman Coulter Diagnostics Recent Developments and Future Plans
2.9 Siemens Healthineers
2.9.1 Siemens Healthineers Details
2.9.2 Siemens Healthineers Major Business
2.9.3 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.9.4 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Siemens Healthineers Recent Developments and Future Plans
2.10 Vazyme
2.10.1 Vazyme Details
2.10.2 Vazyme Major Business
2.10.3 Vazyme Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.10.4 Vazyme Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Vazyme Recent Developments and Future Plans
2.11 Hoyotek
2.11.1 Hoyotek Details
2.11.2 Hoyotek Major Business
2.11.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.11.4 Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Hoyotek Recent Developments and Future Plans
2.12 BGI Genomics
2.12.1 BGI Genomics Details
2.12.2 BGI Genomics Major Business
2.12.3 BGI Genomics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.12.4 BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 BGI Genomics Recent Developments and Future Plans
2.13 Kemei Diagnostics
2.13.1 Kemei Diagnostics Details
2.13.2 Kemei Diagnostics Major Business
2.13.3 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.13.4 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Kemei Diagnostics Recent Developments and Future Plans
2.14 Maya Lightyear
2.14.1 Maya Lightyear Details
2.14.2 Maya Lightyear Major Business
2.14.3 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.14.4 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Maya Lightyear Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Blood Tests for Alzheimer's Diagnosis Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Blood Tests for Alzheimer's Diagnosis by Company Revenue
3.2.2 Top 3 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
3.2.3 Top 6 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
3.3 Blood Tests for Alzheimer's Diagnosis Market: Overall Company Footprint Analysis
3.3.1 Blood Tests for Alzheimer's Diagnosis Market: Region Footprint
3.3.2 Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
3.3.3 Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value and Market Share by Type (2021-2026)
4.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2026)
5.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
6.2 North America Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2032)
6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size by Country
6.3.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
6.3.2 United States Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
6.3.3 Canada Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
6.3.4 Mexico Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
7.2 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
7.3 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country
7.3.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
7.3.2 Germany Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
7.3.3 France Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
7.3.5 Russia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
7.3.6 Italy Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region
8.3.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2032)
8.3.2 China Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8.3.3 Japan Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8.3.4 South Korea Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8.3.5 India Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8.3.7 Australia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
9.2 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
9.3 South America Blood Tests for Alzheimer's Diagnosis Market Size by Country
9.3.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
9.3.2 Brazil Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
9.3.3 Argentina Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country
10.3.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
10.3.2 Turkey Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
10.3.4 UAE Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Blood Tests for Alzheimer's Diagnosis Market Drivers
11.2 Blood Tests for Alzheimer's Diagnosis Market Restraints
11.3 Blood Tests for Alzheimer's Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Blood Tests for Alzheimer's Diagnosis Industry Chain
12.2 Blood Tests for Alzheimer's Diagnosis Upstream Analysis
12.3 Blood Tests for Alzheimer's Diagnosis Midstream Analysis
12.4 Blood Tests for Alzheimer's Diagnosis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood Tests for Alzheimer's Diagnosis by Type
1.3.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type in 2025
1.3.3 Single Biomarker Tests
1.3.4 Multi-Biomarker Panel Tests
1.3.5 Others
1.4 Classification of Blood Tests for Alzheimer's Diagnosis Commercialization Status
1.4.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status: 2021 Versus 2025 Versus 2032
1.4.2 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share Commercialization Status in 2025
1.4.3 Chemiluminescent Immunoassay
1.4.4 Single-Molecule and Ultra-Sensitive Immunoassay
1.4.5 Mass Spectrometry-Based Testing
1.4.6 Others
1.5 Global Blood Tests for Alzheimer's Diagnosis Market by Application
1.5.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Application: 2021 Versus 2025 Versus 2032
1.5.2 Clinical Use
1.5.3 Non-Clinical Use
1.6 Global Blood Tests for Alzheimer's Diagnosis Market Size & Forecast
1.7 Global Blood Tests for Alzheimer's Diagnosis Market Size and Forecast by Region
1.7.1 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
1.7.2 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region, (2021-2032)
1.7.3 North America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
1.7.4 Europe Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
1.7.5 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
1.7.6 South America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
1.7.7 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.1.4 Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments and Future Plans
2.2 Fujirebio
2.2.1 Fujirebio Details
2.2.2 Fujirebio Major Business
2.2.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.2.4 Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Fujirebio Recent Developments and Future Plans
2.3 Sysmex
2.3.1 Sysmex Details
2.3.2 Sysmex Major Business
2.3.3 Sysmex Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.3.4 Sysmex Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sysmex Recent Developments and Future Plans
2.4 Shimadzu
2.4.1 Shimadzu Details
2.4.2 Shimadzu Major Business
2.4.3 Shimadzu Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.4.4 Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Shimadzu Recent Developments and Future Plans
2.5 Diadem
2.5.1 Diadem Details
2.5.2 Diadem Major Business
2.5.3 Diadem Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.5.4 Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Diadem Recent Developments and Future Plans
2.6 Quanterix
2.6.1 Quanterix Details
2.6.2 Quanterix Major Business
2.6.3 Quanterix Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.6.4 Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Quanterix Recent Developments and Future Plans
2.7 ALZpath
2.7.1 ALZpath Details
2.7.2 ALZpath Major Business
2.7.3 ALZpath Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.7.4 ALZpath Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 ALZpath Recent Developments and Future Plans
2.8 Beckman Coulter Diagnostics
2.8.1 Beckman Coulter Diagnostics Details
2.8.2 Beckman Coulter Diagnostics Major Business
2.8.3 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.8.4 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Beckman Coulter Diagnostics Recent Developments and Future Plans
2.9 Siemens Healthineers
2.9.1 Siemens Healthineers Details
2.9.2 Siemens Healthineers Major Business
2.9.3 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.9.4 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Siemens Healthineers Recent Developments and Future Plans
2.10 Vazyme
2.10.1 Vazyme Details
2.10.2 Vazyme Major Business
2.10.3 Vazyme Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.10.4 Vazyme Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Vazyme Recent Developments and Future Plans
2.11 Hoyotek
2.11.1 Hoyotek Details
2.11.2 Hoyotek Major Business
2.11.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.11.4 Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Hoyotek Recent Developments and Future Plans
2.12 BGI Genomics
2.12.1 BGI Genomics Details
2.12.2 BGI Genomics Major Business
2.12.3 BGI Genomics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.12.4 BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 BGI Genomics Recent Developments and Future Plans
2.13 Kemei Diagnostics
2.13.1 Kemei Diagnostics Details
2.13.2 Kemei Diagnostics Major Business
2.13.3 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.13.4 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Kemei Diagnostics Recent Developments and Future Plans
2.14 Maya Lightyear
2.14.1 Maya Lightyear Details
2.14.2 Maya Lightyear Major Business
2.14.3 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.14.4 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Maya Lightyear Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Blood Tests for Alzheimer's Diagnosis Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Blood Tests for Alzheimer's Diagnosis by Company Revenue
3.2.2 Top 3 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
3.2.3 Top 6 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
3.3 Blood Tests for Alzheimer's Diagnosis Market: Overall Company Footprint Analysis
3.3.1 Blood Tests for Alzheimer's Diagnosis Market: Region Footprint
3.3.2 Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
3.3.3 Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value and Market Share by Type (2021-2026)
4.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2026)
5.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
6.2 North America Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2032)
6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size by Country
6.3.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
6.3.2 United States Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
6.3.3 Canada Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
6.3.4 Mexico Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
7.2 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
7.3 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country
7.3.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
7.3.2 Germany Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
7.3.3 France Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
7.3.5 Russia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
7.3.6 Italy Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region
8.3.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2032)
8.3.2 China Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8.3.3 Japan Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8.3.4 South Korea Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8.3.5 India Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
8.3.7 Australia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
9.2 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
9.3 South America Blood Tests for Alzheimer's Diagnosis Market Size by Country
9.3.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
9.3.2 Brazil Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
9.3.3 Argentina Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country
10.3.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2032)
10.3.2 Turkey Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
10.3.4 UAE Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Blood Tests for Alzheimer's Diagnosis Market Drivers
11.2 Blood Tests for Alzheimer's Diagnosis Market Restraints
11.3 Blood Tests for Alzheimer's Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Blood Tests for Alzheimer's Diagnosis Industry Chain
12.2 Blood Tests for Alzheimer's Diagnosis Upstream Analysis
12.3 Blood Tests for Alzheimer's Diagnosis Midstream Analysis
12.4 Blood Tests for Alzheimer's Diagnosis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Commercialization Status, (USD Million), 2021 & 2025 & 2032
Table 3. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2027-2032) & (USD Million)
Table 6. Roche Company Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 9. Roche Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Roche Recent Developments and Future Plans
Table 11. Fujirebio Company Information, Head Office, and Major Competitors
Table 12. Fujirebio Major Business
Table 13. Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 14. Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Fujirebio Recent Developments and Future Plans
Table 16. Sysmex Company Information, Head Office, and Major Competitors
Table 17. Sysmex Major Business
Table 18. Sysmex Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 19. Sysmex Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Shimadzu Company Information, Head Office, and Major Competitors
Table 21. Shimadzu Major Business
Table 22. Shimadzu Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 23. Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Shimadzu Recent Developments and Future Plans
Table 25. Diadem Company Information, Head Office, and Major Competitors
Table 26. Diadem Major Business
Table 27. Diadem Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 28. Diadem Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Diadem Recent Developments and Future Plans
Table 30. Quanterix Company Information, Head Office, and Major Competitors
Table 31. Quanterix Major Business
Table 32. Quanterix Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 33. Quanterix Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Quanterix Recent Developments and Future Plans
Table 35. ALZpath Company Information, Head Office, and Major Competitors
Table 36. ALZpath Major Business
Table 37. ALZpath Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 38. ALZpath Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. ALZpath Recent Developments and Future Plans
Table 40. Beckman Coulter Diagnostics Company Information, Head Office, and Major Competitors
Table 41. Beckman Coulter Diagnostics Major Business
Table 42. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 43. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Beckman Coulter Diagnostics Recent Developments and Future Plans
Table 45. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 46. Siemens Healthineers Major Business
Table 47. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 48. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Siemens Healthineers Recent Developments and Future Plans
Table 50. Vazyme Company Information, Head Office, and Major Competitors
Table 51. Vazyme Major Business
Table 52. Vazyme Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 53. Vazyme Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Vazyme Recent Developments and Future Plans
Table 55. Hoyotek Company Information, Head Office, and Major Competitors
Table 56. Hoyotek Major Business
Table 57. Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 58. Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Hoyotek Recent Developments and Future Plans
Table 60. BGI Genomics Company Information, Head Office, and Major Competitors
Table 61. BGI Genomics Major Business
Table 62. BGI Genomics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 63. BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. BGI Genomics Recent Developments and Future Plans
Table 65. Kemei Diagnostics Company Information, Head Office, and Major Competitors
Table 66. Kemei Diagnostics Major Business
Table 67. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 68. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Kemei Diagnostics Recent Developments and Future Plans
Table 70. Maya Lightyear Company Information, Head Office, and Major Competitors
Table 71. Maya Lightyear Major Business
Table 72. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 73. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Maya Lightyear Recent Developments and Future Plans
Table 75. Global Blood Tests for Alzheimer's Diagnosis Revenue (USD Million) by Players (2021-2026)
Table 76. Global Blood Tests for Alzheimer's Diagnosis Revenue Share by Players (2021-2026)
Table 77. Breakdown of Blood Tests for Alzheimer's Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Blood Tests for Alzheimer's Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 79. Head Office of Key Blood Tests for Alzheimer's Diagnosis Players
Table 80. Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
Table 81. Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
Table 82. Blood Tests for Alzheimer's Diagnosis New Market Entrants and Barriers to Market Entry
Table 83. Blood Tests for Alzheimer's Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Blood Tests for Alzheimer's Diagnosis Consumption Value (USD Million) by Type (2021-2026)
Table 85. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Type (2021-2026)
Table 86. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Type (2027-2032)
Table 87. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026)
Table 88. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Application (2027-2032)
Table 89. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 90. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 91. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 92. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 93. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 94. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 95. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 96. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 97. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 98. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 99. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 100. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 104. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 105. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2027-2032) & (USD Million)
Table 107. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 108. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 109. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 110. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 111. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 112. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 114. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 115. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 116. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 117. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Global Key Players of Blood Tests for Alzheimer's Diagnosis Upstream (Raw Materials)
Table 120. Global Blood Tests for Alzheimer's Diagnosis Typical Customers
Table 1. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Commercialization Status, (USD Million), 2021 & 2025 & 2032
Table 3. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2027-2032) & (USD Million)
Table 6. Roche Company Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 9. Roche Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Roche Recent Developments and Future Plans
Table 11. Fujirebio Company Information, Head Office, and Major Competitors
Table 12. Fujirebio Major Business
Table 13. Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 14. Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Fujirebio Recent Developments and Future Plans
Table 16. Sysmex Company Information, Head Office, and Major Competitors
Table 17. Sysmex Major Business
Table 18. Sysmex Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 19. Sysmex Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Shimadzu Company Information, Head Office, and Major Competitors
Table 21. Shimadzu Major Business
Table 22. Shimadzu Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 23. Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Shimadzu Recent Developments and Future Plans
Table 25. Diadem Company Information, Head Office, and Major Competitors
Table 26. Diadem Major Business
Table 27. Diadem Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 28. Diadem Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Diadem Recent Developments and Future Plans
Table 30. Quanterix Company Information, Head Office, and Major Competitors
Table 31. Quanterix Major Business
Table 32. Quanterix Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 33. Quanterix Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Quanterix Recent Developments and Future Plans
Table 35. ALZpath Company Information, Head Office, and Major Competitors
Table 36. ALZpath Major Business
Table 37. ALZpath Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 38. ALZpath Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. ALZpath Recent Developments and Future Plans
Table 40. Beckman Coulter Diagnostics Company Information, Head Office, and Major Competitors
Table 41. Beckman Coulter Diagnostics Major Business
Table 42. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 43. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Beckman Coulter Diagnostics Recent Developments and Future Plans
Table 45. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 46. Siemens Healthineers Major Business
Table 47. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 48. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Siemens Healthineers Recent Developments and Future Plans
Table 50. Vazyme Company Information, Head Office, and Major Competitors
Table 51. Vazyme Major Business
Table 52. Vazyme Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 53. Vazyme Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Vazyme Recent Developments and Future Plans
Table 55. Hoyotek Company Information, Head Office, and Major Competitors
Table 56. Hoyotek Major Business
Table 57. Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 58. Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Hoyotek Recent Developments and Future Plans
Table 60. BGI Genomics Company Information, Head Office, and Major Competitors
Table 61. BGI Genomics Major Business
Table 62. BGI Genomics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 63. BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. BGI Genomics Recent Developments and Future Plans
Table 65. Kemei Diagnostics Company Information, Head Office, and Major Competitors
Table 66. Kemei Diagnostics Major Business
Table 67. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 68. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Kemei Diagnostics Recent Developments and Future Plans
Table 70. Maya Lightyear Company Information, Head Office, and Major Competitors
Table 71. Maya Lightyear Major Business
Table 72. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 73. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Maya Lightyear Recent Developments and Future Plans
Table 75. Global Blood Tests for Alzheimer's Diagnosis Revenue (USD Million) by Players (2021-2026)
Table 76. Global Blood Tests for Alzheimer's Diagnosis Revenue Share by Players (2021-2026)
Table 77. Breakdown of Blood Tests for Alzheimer's Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Blood Tests for Alzheimer's Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 79. Head Office of Key Blood Tests for Alzheimer's Diagnosis Players
Table 80. Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
Table 81. Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
Table 82. Blood Tests for Alzheimer's Diagnosis New Market Entrants and Barriers to Market Entry
Table 83. Blood Tests for Alzheimer's Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Blood Tests for Alzheimer's Diagnosis Consumption Value (USD Million) by Type (2021-2026)
Table 85. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Type (2021-2026)
Table 86. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Type (2027-2032)
Table 87. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026)
Table 88. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Application (2027-2032)
Table 89. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 90. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 91. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 92. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 93. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 94. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 95. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 96. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 97. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 98. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 99. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 100. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 104. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 105. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2027-2032) & (USD Million)
Table 107. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 108. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 109. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 110. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 111. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 112. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 114. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 115. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 116. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 117. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Global Key Players of Blood Tests for Alzheimer's Diagnosis Upstream (Raw Materials)
Table 120. Global Blood Tests for Alzheimer's Diagnosis Typical Customers
LIST OF FIGURES
Figure 1. Blood Tests for Alzheimer's Diagnosis Picture
Figure 2. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type in 2025
Figure 4. Single Biomarker Tests
Figure 5. Multi-Biomarker Panel Tests
Figure 6. Others
Figure 7. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Commercialization Status, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share Commercialization Status in 2025
Figure 9. Chemiluminescent Immunoassay
Figure 10. Single-Molecule and Ultra-Sensitive Immunoassay
Figure 11. Mass Spectrometry-Based Testing
Figure 12. Others
Figure 13. Commercialized Products
Figure 14. Products under Development or Registration
Figure 15. Research Use Only Products
Figure 16. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application in 2025
Figure 18. Clinical Use Picture
Figure 19. Non-Clinical Use Picture
Figure 20. Global Blood Tests for Alzheimer's Diagnosis Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Blood Tests for Alzheimer's Diagnosis Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Market Blood Tests for Alzheimer's Diagnosis Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 23. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 24. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region in 2025
Figure 25. North America Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 26. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 27. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 28. South America Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 29. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 30. Company Three Recent Developments and Future Plans
Figure 31. Global Blood Tests for Alzheimer's Diagnosis Revenue Share by Players in 2025
Figure 32. Blood Tests for Alzheimer's Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 33. Market Share of Blood Tests for Alzheimer's Diagnosis by Player Revenue in 2025
Figure 34. Top 3 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
Figure 35. Top 6 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
Figure 36. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Type (2021-2026)
Figure 37. Global Blood Tests for Alzheimer's Diagnosis Market Share Forecast by Type (2027-2032)
Figure 38. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Application (2021-2026)
Figure 39. Global Blood Tests for Alzheimer's Diagnosis Market Share Forecast by Application (2027-2032)
Figure 40. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 41. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 42. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 43. United States Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 44. Canada Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 45. Mexico Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 47. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 48. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 50. France Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 55. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 56. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 57. China Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 58. Japan Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 59. South Korea Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 60. India Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 61. Southeast Asia Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 62. Australia Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 63. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 64. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 65. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 66. Brazil Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 67. Argentina Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 68. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 69. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 70. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 71. Turkey Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 73. UAE Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 74. Blood Tests for Alzheimer's Diagnosis Market Drivers
Figure 75. Blood Tests for Alzheimer's Diagnosis Market Restraints
Figure 76. Blood Tests for Alzheimer's Diagnosis Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Blood Tests for Alzheimer's Diagnosis Industrial Chain
Figure 79. Methodology
Figure 80. Research Process and Data Source
Figure 1. Blood Tests for Alzheimer's Diagnosis Picture
Figure 2. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type in 2025
Figure 4. Single Biomarker Tests
Figure 5. Multi-Biomarker Panel Tests
Figure 6. Others
Figure 7. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Commercialization Status, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share Commercialization Status in 2025
Figure 9. Chemiluminescent Immunoassay
Figure 10. Single-Molecule and Ultra-Sensitive Immunoassay
Figure 11. Mass Spectrometry-Based Testing
Figure 12. Others
Figure 13. Commercialized Products
Figure 14. Products under Development or Registration
Figure 15. Research Use Only Products
Figure 16. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application in 2025
Figure 18. Clinical Use Picture
Figure 19. Non-Clinical Use Picture
Figure 20. Global Blood Tests for Alzheimer's Diagnosis Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Blood Tests for Alzheimer's Diagnosis Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Market Blood Tests for Alzheimer's Diagnosis Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 23. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 24. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region in 2025
Figure 25. North America Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 26. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 27. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 28. South America Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 29. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 30. Company Three Recent Developments and Future Plans
Figure 31. Global Blood Tests for Alzheimer's Diagnosis Revenue Share by Players in 2025
Figure 32. Blood Tests for Alzheimer's Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 33. Market Share of Blood Tests for Alzheimer's Diagnosis by Player Revenue in 2025
Figure 34. Top 3 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
Figure 35. Top 6 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2025
Figure 36. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Type (2021-2026)
Figure 37. Global Blood Tests for Alzheimer's Diagnosis Market Share Forecast by Type (2027-2032)
Figure 38. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Application (2021-2026)
Figure 39. Global Blood Tests for Alzheimer's Diagnosis Market Share Forecast by Application (2027-2032)
Figure 40. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 41. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 42. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 43. United States Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 44. Canada Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 45. Mexico Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 47. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 48. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 50. France Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 55. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 56. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 57. China Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 58. Japan Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 59. South Korea Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 60. India Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 61. Southeast Asia Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 62. Australia Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 63. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 64. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 65. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 66. Brazil Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 67. Argentina Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 68. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 69. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 70. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 71. Turkey Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 73. UAE Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 74. Blood Tests for Alzheimer's Diagnosis Market Drivers
Figure 75. Blood Tests for Alzheimer's Diagnosis Market Restraints
Figure 76. Blood Tests for Alzheimer's Diagnosis Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Blood Tests for Alzheimer's Diagnosis Industrial Chain
Figure 79. Methodology
Figure 80. Research Process and Data Source
